Login / Signup

Emergence of tet(X2) in Acinetobacter pittii confers clinical resistance to tigecycline.

Changrui QianZhexiao MaLuozhu FengWenhui GuoYijia HanYi ZhangChunquan XuJianming CaoZhexiao Ma
Published in: The Journal of antimicrobial chemotherapy (2023)
Our study demonstrates that tet(X2) is a determinant conferring clinical resistance to tigecycline in Acinetobacter species. The emergence of Tn7533 may lead to the potential dissemination of tigecycline and carbapenem resistance in Acinetobacter, which requires continuous monitoring.
Keyphrases
  • acinetobacter baumannii
  • multidrug resistant
  • drug resistant
  • pseudomonas aeruginosa
  • klebsiella pneumoniae
  • gram negative
  • risk assessment
  • escherichia coli